1MCS

WisdomTree FTSE 250 1x Daily Short

ETFs & Funds · GBX · LSE

1MCSETFT212

Price

£3,279

+0.80%

Cap

Earnings

30d Trend

-3.4%

1MCS
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

16% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level30
Quality50
Momentum45
Technical39
Fundamentals50

Raw weighted: 49×Macro 0.99 (1%)=49

RISK

30/100
90d Volatility
16.0%Low
ATR %
1.4%Low daily moves
Max Drawdown (1Y)
-11.5%Resilient

QUALITY

50/100

MOMENTUM

45/100
12-1M Momentum
-6.1%Downtrend
6-1M Momentum
-1.2%Flat
1M Return
-5.1%Recent pullback

TECHNICAL

39/100
RSI (14)
31.8Neutral
Price vs SMA200
-5.7%Bearish trend
MACD
-10.83Bearish momentum
Bollinger Band
-7%Near lower band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.296Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 60%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months43
3-12 months35
1-5+ years48

Moderate long-term case — not compelling enough for a multi-year commitment

BRAIN47'S ASSESSMENT

I rate WisdomTree FTSE 250 1x Daily Short at 49/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is risk management at 70/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-5.1%

3 MONTHS

+0.1%

12 MONTHS

-11.2%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Moderate long-term case — not compelling enough for a multi-year commitment. low-risk profile and Quality (50) are the primary strengths. I note that technical is the weakest area at 39/100 — this warrants monitoring. Historical volatility is normal at 16%. I classify this as a defensive holding — low volatility and resilient fundamentals provide portfolio ballast.

defensiveScore: 49/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.